Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study

NCT01813773 is registered in ClinicalTrials.gov with Ophthalmic Consultants of Long Island as lead sponsor.

NCT NCT01813773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01813773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Lead sponsor
Ophthalmic Consultants of Long Island
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2013
Completion date
April 30, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy